Back
Puma Biotechnology, Inc. 10K Form
Sell
45
PBYI
Puma Biotechnology, Inc.
Last Price:
$5.28
Seasonality Move:
16.8%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive PBYI News And Ratings
See the #1 stock for the next 7 days that we like better than PBYI
PBYI Financial Statistics
Sales & Book Value
| Annual Sales: | $230.5M |
|---|---|
| Cash Flow: | $9.7M |
| Price / Cash Flow: | 6.18 |
| Annual Sales: | $2.29 |
| Price / Book: | 2.31 |
Profitability
| EPS (TTM): | 0.74070 |
|---|---|
| Net Income (TTM): | $37M |
| Gross Margin: | $166.1M |
| Return on Equity: | 38.49% |
| Return on Assets: | 17.96% |
Puma Biotechnology, Inc. Earnings Forecast
Key Puma Biotechnology, Inc. Financial Ratios
-
The Gross Profit Margin over the past 17 years for PBYI is 72.06%.
-
The Selling, General & Administrative Expenses for PBYI have been equal to 34.78% of Gross Profit Margin.
-
The Research & Development expenses have been 23.84% of Revenue.
-
The Interest Expense is 41.13% of Operating Income.
-
The Net Earning history of PBYI is 13.14% of Total Revenues.
-
Per Share Earnings over the last 17 years have been positive in 9 years.
Puma Biotechnology, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | PBYI |
| CUSIP: | 74587V |
| Website: | pumabiotechnology.com |
Debt
| Debt-to-Equity Ratio: | 0.36 |
|---|---|
| Current Ratio: | 1.74 |
| Quick Ratio: | 1.57 |
Price-to-Earnings
| Trailing P/E Ratio: | 8.58 |
|---|---|
| Forward P/E Ratio: | 9.62 |
PBYI Technical Analysis vs Fundamental Analysis
Sell
45
Puma Biotechnology, Inc. (PBYI)
is a Sell
Is Puma Biotechnology, Inc. a Buy or a Sell?
-
Puma Biotechnology, Inc. stock is rated a SellThe current Puma Biotechnology, Inc. [PBYI] share price is $5.29. The Score for PBYI is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.